Zevra Therapeutics
ZVRA
ZVRA
109 hedge funds and large institutions have $283M invested in Zevra Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8.52% more ownership
Funds ownership: 55.04% → 63.56% (+8.5%)
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
1% more funds holding
Funds holding: 108 → 109 (+1)
Holders
109
Holding in Top 10
4
Calls
$3.95M
Puts
$539K
Top Buyers
| 1 | +$25M | |
| 2 | +$8M | |
| 3 | +$6.58M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.97M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.33M |
Top Sellers
| 1 | -$4.87M | |
| 2 | -$3.64M | |
| 3 | -$2.68M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.43M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$1.23M |